Evidence map›Paper›PMID 42429097›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2026

[Bushen Yijing Formula attenuates amyloid β-protein deposi-tion and oxidative damage in

Yunwei Lu, Deyu Li, Yingchao Hu, Lei Lu, Guran Yu

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yunwei LuDepartment of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China);*Now works in the Department of Neurology and Psychology, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen Traditional Chinese Medicine Hospital. 417213243@qq.com.
Deyu LiDepartment of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China); 525956500@qq.com.
Yingchao HuDepartment of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China);
Lei LuDepartment of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China);
Guran YuDepartment of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China); dr.ygrdf@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the protective effects of Chinese medicine Bushen Yijing Formula against amyloid β-protein (Aβ) deposition and oxidative damage using models of

methodsThe

resultsCompared with the normal control group, Bushen Yijing Formula significantly extended the lifespan of N2 nematodes under both oxidative stress and normal conditions (all

conclusionsBushen Yijing Formula alleviates Aβ deposition and its neurotoxicity, enhances antioxidant capacity, and attenuates oxidative stress injury in model nematodes, likely through stable binding and regulation of the FOXO/Nrf2 signaling pathway.

Indexed as

Amyloid beta-PeptidesCaenorhabditis elegansDrugs, Chinese HerbalOxidative StressAnimalsAntioxidantsMalondialdehydeMolecular Docking SimulationReactive Oxygen SpeciesSuperoxide DismutaseAmyloid beta-PeptidesAntioxidantsDrugs, Chinese HerbalMalondialdehydeReactive Oxygen SpeciesSuperoxide DismutaseAlzheimer’s diseaseAmyloid β-proteinBushen Yijing FormulaCaenorhabditis elegansOxida-tive stress

Identifiers

PMID42429097
PMCPMC13439443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.